Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28273028

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2017 Mar 9
First author
Hochhaus A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2017 Mar 9;376(10):982-983. doi: 10.1056/NEJMe1700833.
    note
    Source null
    related pmid
    28273011
    relationship
    Comment in
  2. citation
    Internist (Berl). 2017 Nov;58(11):1220-1221. doi: 10.1007/s00108-017-0322-0.
    note
    Source null
    related pmid
    28929180
    relationship
    Comment in

Authors and identifiers

  1. name
    Hochhaus A
    type
    Author
  2. name
    Larson RA
    type
    Author
  3. name
    Guilhot F
    type
    Author
  4. name
    Radich JP
    type
    Author
  5. name
    Branford S
    type
    Author
  6. name
    Hughes TP
    type
    Author
  7. name
    Baccarani M
    type
    Author
  8. name
    Deininger MW
    type
    Author
  9. name
    Cervantes F
    type
    Author
  10. name
    Fujihara S
    type
    Author
  11. name
    Ortmann CE
    type
    Author
  12. name
    Menssen HD
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hochhaus A
    type
    Author
  2. name
    Larson RA
    type
    Author
  3. name
    Guilhot F
    type
    Author
  4. name
    Radich JP
    type
    Author
  5. name
    Branford S
    type
    Author
  6. name
    Hughes TP
    type
    Author
  7. name
    Baccarani M
    type
    Author
  8. name
    Deininger MW
    type
    Author
  9. name
    Cervantes F
    type
    Author
  10. name
    Fujihara S
    type
    Author
  11. name
    Ortmann CE
    type
    Author
  12. name
    Menssen HD
    type
    Author
bibliography ids
  1. nci-bib-95b171078cc63faac4631d20
book metadata
content sha256
b652ced9356ddb2ec9ce57dff31e883891ea889d9f2db0342236ebda26815cc4
document type
citation
dois
  1. 10.1056/NEJMoa1609324
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:28273028
immutable id
pubmed:28273028@b652ced9356ddb2ec9ce57dff31e883891ea889d9f2db0342236ebda26815cc4
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
10
name
The New England journal of medicine
nlm unique id
0255562
pages
917-927
volume
376
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2017 Mar 9;376(10):982-983. doi: 10.1056/NEJMe1700833.
    note
    Source null
    related pmid
    28273011
    relationship
    Comment in
  2. citation
    Internist (Berl). 2017 Nov;58(11):1220-1221. doi: 10.1007/s00108-017-0322-0.
    note
    Source null
    related pmid
    28929180
    relationship
    Comment in
outcomes validated
false
pmid
28273028
provenance
batch id
7a1288ac8bb5f9826304
provider
NCBI PubMed ESummary
record sha256
91529de57b0b61eb38c3dcd36ae14061f1b740a75c588c006e28fd60c5653f32
response sha256
0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
retrieved at
2026-09-09T23:47:23.138359+00:00
publication date
display
2017 Mar 9
precision
day
year
2017
publication types
  1. Journal Article
  2. Multicenter Study
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28273028/
title
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.

Preserved source evidence · Not medical advice